
St. Louis Arch Angels
Description
The St. Louis Arch Angels is a prominent angel investment group established in 2005, operating as a 501(c)(6) not-for-profit corporation. Its core mission is to catalyze economic growth by providing crucial early-stage capital to promising startup companies. While primarily focused on the St. Louis region, the group also extends its reach to compelling opportunities beyond its immediate geographical area, fostering a broader entrepreneurial ecosystem.
The group targets high-growth potential companies across a diverse range of sectors. Their investment interests span bioscience, advanced manufacturing, information technology, and consumer products. This broad sector focus allows them to support innovation across various industries, reflecting the evolving landscape of the startup economy. They are particularly keen on ventures that demonstrate significant scalability and a clear path to market disruption.
Since its inception, the St. Louis Arch Angels has made a substantial impact on the early-stage funding landscape, having invested over $60 million into more than 100 companies. Their initial investments typically range from $100,000 to $500,000, providing essential seed and early-stage funding. While these initial checks are significant, the group often follows on with additional capital, with the average total investment per company over multiple rounds reaching between $500,000 and $1,000,000, underscoring their commitment to long-term support for their portfolio companies.
Investor Profile
St. Louis Arch Angels has backed more than 72 startups, with 0 new investments in the last 12 months alone. The firm has led 30 rounds, about 42% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Argentina.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
- Typical check size: $100K – $500K.
Stage Focus
- Seed (58%)
- Series A (13%)
- Series Unknown (13%)
- Series B (6%)
- Angel (6%)
- Pre Seed (4%)
- Private Equity (1%)
Country Focus
- United States (99%)
- Argentina (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Software
- Pharmaceutical
- Medical
- Information Technology
- Life Science
- Health Diagnostics
- Agtech
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.